FITAH Medical Microsphere Platform, established in 2020 and based in Huadu District, Guangzhou, Guangdong Province, specializes in high-end microsphere raw materials — including PLLA, PCL, CaHA, and PDRN — for the medical aesthetic regeneration sector, supplying compliant, registered, and traceable implant-grade materials to overseas device manufacturers, medical aesthetic institutions, and equipment companies. Backed by R&D collaboration with a doctoral team from Jinan University and an ISO 13485/GMP-certified manufacturing system, the company offers OEM/ODM services with DMF documentation supporting multi-market registration, automated mass production with stable lead times, customized formulation development under NDA protection, and cold chain logistics support; since launching its HA+PLA and PCL regenerative products and OEM/ODM services in 2024, it has expanded into Southeast Asia and Europe. Offering CRO, CMO, CSO, and CDMO contract services delivered FOB, CIF, or CIP against L/C, L/L, T/T, or D/P payment, FITAH sells across Asia, North America, and Australasia, and is recognized for its brand, international certifications, experienced R&D team, and high-quality, buyer-responsive service.
Keine Kommentare verfügbar.
Bewertung & Kommentar hinterlassen